Herbert Skip Virgin
2018
In 2018, Herbert Skip Virgin earned a total compensation of $2.2M as Executive Vice President, Research and Chief Scientific Officer at Vir Biotechnology.
Compensation breakdown
| Bonus | $600,000 |
|---|---|
| Non-Equity Incentive Plan | $259,000 |
| Option Awards | $627,750 |
| Salary | $592,308 |
| Other | $84,000 |
| Total | $2,163,058 |
Virgin received $627.8K in option awards, accounting for 29% of the total pay in 2018.
Virgin also received $600K in bonus, $259K in non-equity incentive plan, $592.3K in salary and $84K in other compensation.
Rankings
In 2018, Herbert Skip Virgin's compensation ranked 5,319th out of 14,244 executives tracked by ExecPay. In other words, Virgin earned more than 62.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,319 out of 14,244 | 63rd |
Division Manufacturing | 2,009 out of 5,765 | 65th |
Major group Chemicals And Allied Products | 736 out of 2,128 | 65th |
Industry group Drugs | 616 out of 1,817 | 66th |
Industry Biological Products, Except Diagnostic Substances | 124 out of 339 | 63rd |
Source: SEC filing on April 6, 2020.
Virgin's colleagues
We found one more compensation record of an executive who worked with Herbert Skip Virgin at Vir Biotechnology in 2018.
2018
George Scangos
Vir Biotechnology